These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25972406)

  • 1. Cross-Reactive Epitopes in Borrelia burgdorferi p66.
    Arnaboldi PM; Dattwyler RJ
    Clin Vaccine Immunol; 2015 Jul; 22(7):840-3. PubMed ID: 25972406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease.
    Toumanios C; Prisco L; Dattwyler RJ; Arnaboldi PM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immune response to the variable surface loop antigen of P66 of Borrelia burgdorferi sensu lato species in geographically diverse populations of lyme borreliosis patients.
    Ornstein K; Ostberg Y; Bunikis J; Noppa L; Berglund J; Norrby R; Bergström S
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1382-4. PubMed ID: 12414780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.
    Signorino G; Arnaboldi PM; Petzke MM; Dattwyler RJ
    Clin Vaccine Immunol; 2014 May; 21(5):704-11. PubMed ID: 24623628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of multiple antibody epitopes throughout Borrelia burgdorferi p66, a candidate adhesin, in patients with early or late manifestations of Lyme disease.
    Ntchobo H; Rothermel H; Chege W; Steere AC; Coburn J
    Infect Immun; 2001 Mar; 69(3):1953-6. PubMed ID: 11179382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
    Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
    Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.
    Jacek E; Tang KS; Komorowski L; Ajamian M; Probst C; Stevenson B; Wormser GP; Marques AR; Alaedini A
    J Immunol; 2016 Feb; 196(3):1036-43. PubMed ID: 26718339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.
    Arnaboldi PM; Sambir M; Dattwyler RJ
    Clin Vaccine Immunol; 2014 Oct; 21(10):1426-36. PubMed ID: 25121778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of 41 kD Flagellin Gene and Its Human B-Cell Epitope in
    Liu H; Liu W; Hou X; Zhang L; Hao Q; Wan K
    Biomed Res Int; 2016; 2016():1327320. PubMed ID: 28042565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid domains of
    Curtis MW; Fierros CH; Hahn BL; Surdel MC; Kessler J; Anderson PN; Vandewalle-Capo M; Bonde M; Zhu J; Bergström S; Coburn J
    Front Cell Infect Microbiol; 2022; 12():991689. PubMed ID: 36211976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P66 porins are present in both Lyme disease and relapsing fever spirochetes: a comparison of the biophysical properties of P66 porins from six Borrelia species.
    Bárcena-Uribarri I; Thein M; Sacher A; Bunikis I; Bonde M; Bergström S; Benz R
    Biochim Biophys Acta; 2010 Jun; 1798(6):1197-203. PubMed ID: 20188698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3.
    Coburn J; Cugini C
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7301-6. PubMed ID: 12748384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrelia burgdorferi complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to nondenatured structural determinants.
    Rossmann E; Kitiratschky V; Hofmann H; Kraiczy P; Simon MM; Wallich R
    Infect Immun; 2006 Dec; 74(12):7024-8. PubMed ID: 17000728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.
    Chandra A; Latov N; Wormser GP; Marques AR; Alaedini A
    Clin Immunol; 2011 Oct; 141(1):103-10. PubMed ID: 21778118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
    Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
    J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.
    Exner MM; Wu X; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 May; 68(5):2647-54. PubMed ID: 10768956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of Borrelia burgdorferi genostrains among patients with Lyme disease].
    Biesiada G; Czepiel J; Salamon D; Garlicki A; Dziubek A; Maziarz B; Mach T
    Przegl Lek; 2009; 66(9):511-2. PubMed ID: 21033412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease.
    Maccallini P; Bonin S; Trevisan G
    Med Hypotheses; 2018 Jan; 110():1-8. PubMed ID: 29317049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.